nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—Gemcitabine—pancreatic cancer	0.284	1	CrCtD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—pancreatic cancer	0.207	0.515	CiPCiCtD
Azacitidine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—pancreatic cancer	0.195	0.485	CiPCiCtD
Azacitidine—CDA—Gemcitabine—pancreatic cancer	0.134	1	CbGbCtD
Azacitidine—Cytarabine—Gemcitabine—pancreatic cancer	0.0575	0.525	CrCrCtD
Azacitidine—Decitabine—Gemcitabine—pancreatic cancer	0.0521	0.475	CrCrCtD
Azacitidine—CDA—Pyrimidine salvage reactions—TYMP—pancreatic cancer	0.00279	0.147	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00197	0.103	CbGpPWpGaD
Azacitidine—CDA—Pyrimidine metabolism—TYMP—pancreatic cancer	0.00128	0.0669	CbGpPWpGaD
Azacitidine—CDA—Pyrimidine metabolism—DPYD—pancreatic cancer	0.00101	0.053	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000988	0.0518	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000784	0.0411	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CFLAR—pancreatic cancer	0.000654	0.0343	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—NDRG1—pancreatic cancer	0.000654	0.0343	CbGpPWpGaD
Azacitidine—CDA—Pyrimidine metabolism—TYMS—pancreatic cancer	0.000576	0.0302	CbGpPWpGaD
Azacitidine—DNMT3A—One Carbon Metabolism—TYMS—pancreatic cancer	0.000531	0.0279	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—TYMP—pancreatic cancer	0.000497	0.026	CbGpPWpGaD
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—TYMS—pancreatic cancer	0.000477	0.025	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000447	0.0234	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—DPYD—pancreatic cancer	0.000394	0.0207	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—GADD45A—pancreatic cancer	0.000377	0.0198	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CHD3—pancreatic cancer	0.00036	0.0189	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—TYMS—pancreatic cancer	0.000359	0.0188	CbGpPWpGaD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—EZH2—pancreatic cancer	0.000353	0.0185	CbGpPWpGaD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—TYMS—pancreatic cancer	0.000322	0.0169	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—SMAD4—pancreatic cancer	0.000283	0.0148	CbGpPWpGaD
Azacitidine—Fludarabine—SLC29A1—pancreatic cancer	0.000248	0.138	CrCbGaD
Azacitidine—Ribavirin—SLC29A1—pancreatic cancer	0.000247	0.138	CrCbGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—EZH2—pancreatic cancer	0.000238	0.0125	CbGpPWpGaD
Azacitidine—Gemcitabine—SLC29A1—pancreatic cancer	0.000234	0.131	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—TSC2—pancreatic cancer	0.000231	0.0121	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—EZH2—pancreatic cancer	0.000226	0.0119	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—TYMS—pancreatic cancer	0.000224	0.0118	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—HSPA1B—pancreatic cancer	0.00018	0.101	CrCbGaD
Azacitidine—Adenosine triphosphate—ACVR1B—pancreatic cancer	0.00018	0.101	CrCbGaD
Azacitidine—Adenosine triphosphate—HSPA1A—pancreatic cancer	0.000165	0.0921	CrCbGaD
Azacitidine—Cytarabine—SLC29A1—pancreatic cancer	0.00016	0.0892	CrCbGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—EZH2—pancreatic cancer	0.000153	0.00801	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000148	0.00777	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000145	0.0076	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—MET—pancreatic cancer	0.000141	0.00739	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—pancreatic cancer	0.00014	0.00733	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—PPARG—pancreatic cancer	0.000128	0.00671	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—RB1—pancreatic cancer	0.000123	0.00643	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CCND1—pancreatic cancer	0.000122	0.00638	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—pancreatic cancer	0.000112	0.00588	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—pancreatic cancer	0.000108	0.00565	CbGpPWpGaD
Azacitidine—Glucosamine—MMP9—pancreatic cancer	0.000101	0.0561	CrCbGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	9.82e-05	0.00515	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—CHD3—pancreatic cancer	9.53e-05	0.005	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND1—pancreatic cancer	9.1e-05	0.00477	CbGpPWpGaD
Azacitidine—Gemcitabine—TYMS—pancreatic cancer	8.34e-05	0.0465	CrCbGaD
Azacitidine—DNMT3A—Gene Expression—NR5A2—pancreatic cancer	7.98e-05	0.00419	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	7.29e-05	0.00383	CbGpPWpGaD
Azacitidine—Glucosamine—TNF—pancreatic cancer	6.6e-05	0.0368	CrCbGaD
Azacitidine—Adenosine triphosphate—AKT1—pancreatic cancer	6.47e-05	0.0361	CrCbGaD
Azacitidine—DNMT1—Gene Expression—CHD3—pancreatic cancer	6.44e-05	0.00338	CbGpPWpGaD
Azacitidine—Adenosine monophosphate—SRC—pancreatic cancer	6.38e-05	0.0356	CrCbGaD
Azacitidine—CDA—Metabolism—PRSS1—pancreatic cancer	5.95e-05	0.00312	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	5.85e-05	0.00307	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NR5A2—pancreatic cancer	5.39e-05	0.00283	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CCND1—pancreatic cancer	5.2e-05	0.00273	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ARG2—pancreatic cancer	5.16e-05	0.00271	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	4.81e-05	0.00252	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—MEN1—pancreatic cancer	4.59e-05	0.00241	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TYMP—pancreatic cancer	4.51e-05	0.00237	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NOTCH4—pancreatic cancer	4.35e-05	0.00228	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—HSPA1B—pancreatic cancer	4.15e-05	0.00218	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—EZH2—pancreatic cancer	3.78e-05	0.00198	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NOTCH3—pancreatic cancer	3.7e-05	0.00194	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GLP1R—pancreatic cancer	3.64e-05	0.00191	CbGpPWpGaD
Azacitidine—CDA—Metabolism—DPYD—pancreatic cancer	3.58e-05	0.00188	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—HSPA1A—pancreatic cancer	3.5e-05	0.00184	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC2A2—pancreatic cancer	3.39e-05	0.00178	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—MEN1—pancreatic cancer	3.1e-05	0.00162	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NOTCH4—pancreatic cancer	2.94e-05	0.00154	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—HSPA1B—pancreatic cancer	2.8e-05	0.00147	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—SMAD4—pancreatic cancer	2.78e-05	0.00146	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CD44—pancreatic cancer	2.63e-05	0.00138	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—EZH2—pancreatic cancer	2.55e-05	0.00134	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GCG—pancreatic cancer	2.52e-05	0.00132	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NOTCH3—pancreatic cancer	2.5e-05	0.00131	CbGpPWpGaD
Azacitidine—CDA—Metabolism—STK11—pancreatic cancer	2.37e-05	0.00124	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—HSPA1A—pancreatic cancer	2.36e-05	0.00124	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NOTCH1—pancreatic cancer	2.05e-05	0.00108	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TYMS—pancreatic cancer	2.04e-05	0.00107	CbGpPWpGaD
Azacitidine—Abdominal distension—Doxorubicin—pancreatic cancer	2.02e-05	0.000414	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	2.01e-05	0.000413	CcSEcCtD
Azacitidine—Urticaria—Fluorouracil—pancreatic cancer	2.01e-05	0.000412	CcSEcCtD
Azacitidine—Headache—Sunitinib—pancreatic cancer	2.01e-05	0.000412	CcSEcCtD
Azacitidine—Syncope—Docetaxel—pancreatic cancer	2e-05	0.000411	CcSEcCtD
Azacitidine—Dysphagia—Doxorubicin—pancreatic cancer	2e-05	0.000411	CcSEcCtD
Azacitidine—Leukopenia—Docetaxel—pancreatic cancer	2e-05	0.000411	CcSEcCtD
Azacitidine—Body temperature increased—Fluorouracil—pancreatic cancer	2e-05	0.00041	CcSEcCtD
Azacitidine—Loss of consciousness—Docetaxel—pancreatic cancer	1.96e-05	0.000403	CcSEcCtD
Azacitidine—Weight decreased—Epirubicin—pancreatic cancer	1.96e-05	0.000402	CcSEcCtD
Azacitidine—Cough—Docetaxel—pancreatic cancer	1.95e-05	0.0004	CcSEcCtD
Azacitidine—Hypersensitivity—Irinotecan—pancreatic cancer	1.94e-05	0.000399	CcSEcCtD
Azacitidine—Pneumonia—Epirubicin—pancreatic cancer	1.94e-05	0.000398	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—PPARG—pancreatic cancer	1.94e-05	0.00102	CbGpPWpGaD
Azacitidine—Convulsion—Docetaxel—pancreatic cancer	1.94e-05	0.000397	CcSEcCtD
Azacitidine—Hypertension—Docetaxel—pancreatic cancer	1.93e-05	0.000396	CcSEcCtD
Azacitidine—Infestation—Epirubicin—pancreatic cancer	1.93e-05	0.000396	CcSEcCtD
Azacitidine—Infestation NOS—Epirubicin—pancreatic cancer	1.93e-05	0.000396	CcSEcCtD
Azacitidine—Bronchitis—Doxorubicin—pancreatic cancer	1.93e-05	0.000395	CcSEcCtD
Azacitidine—Myalgia—Docetaxel—pancreatic cancer	1.9e-05	0.00039	CcSEcCtD
Azacitidine—Chest pain—Docetaxel—pancreatic cancer	1.9e-05	0.00039	CcSEcCtD
Azacitidine—Arthralgia—Docetaxel—pancreatic cancer	1.9e-05	0.00039	CcSEcCtD
Azacitidine—Nausea—Sunitinib—pancreatic cancer	1.9e-05	0.00039	CcSEcCtD
Azacitidine—Pancytopenia—Doxorubicin—pancreatic cancer	1.9e-05	0.00039	CcSEcCtD
Azacitidine—Renal failure—Epirubicin—pancreatic cancer	1.9e-05	0.000389	CcSEcCtD
Azacitidine—Asthenia—Irinotecan—pancreatic cancer	1.89e-05	0.000389	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	1.89e-05	0.000388	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—SMAD4—pancreatic cancer	1.88e-05	0.000986	CbGpPWpGaD
Azacitidine—Stomatitis—Epirubicin—pancreatic cancer	1.88e-05	0.000386	CcSEcCtD
Azacitidine—Urinary tract infection—Epirubicin—pancreatic cancer	1.88e-05	0.000385	CcSEcCtD
Azacitidine—Dysuria—Doxorubicin—pancreatic cancer	1.87e-05	0.000384	CcSEcCtD
Azacitidine—Neutropenia—Doxorubicin—pancreatic cancer	1.87e-05	0.000384	CcSEcCtD
Azacitidine—Hypersensitivity—Fluorouracil—pancreatic cancer	1.86e-05	0.000382	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	1.86e-05	0.000382	CcSEcCtD
Azacitidine—Asthenia—Gemcitabine—pancreatic cancer	1.84e-05	0.000378	CcSEcCtD
Azacitidine—Haematuria—Epirubicin—pancreatic cancer	1.84e-05	0.000377	CcSEcCtD
Azacitidine—Confusional state—Docetaxel—pancreatic cancer	1.84e-05	0.000377	CcSEcCtD
Azacitidine—Hepatobiliary disease—Epirubicin—pancreatic cancer	1.82e-05	0.000374	CcSEcCtD
Azacitidine—Oedema—Docetaxel—pancreatic cancer	1.82e-05	0.000374	CcSEcCtD
Azacitidine—Anaphylactic shock—Docetaxel—pancreatic cancer	1.82e-05	0.000374	CcSEcCtD
Azacitidine—Epistaxis—Epirubicin—pancreatic cancer	1.82e-05	0.000373	CcSEcCtD
Azacitidine—Pruritus—Gemcitabine—pancreatic cancer	1.82e-05	0.000373	CcSEcCtD
Azacitidine—Infection—Docetaxel—pancreatic cancer	1.81e-05	0.000372	CcSEcCtD
Azacitidine—Weight decreased—Doxorubicin—pancreatic cancer	1.81e-05	0.000372	CcSEcCtD
Azacitidine—Sinusitis—Epirubicin—pancreatic cancer	1.81e-05	0.000371	CcSEcCtD
Azacitidine—Diarrhoea—Irinotecan—pancreatic cancer	1.81e-05	0.00037	CcSEcCtD
Azacitidine—Agranulocytosis—Epirubicin—pancreatic cancer	1.8e-05	0.000369	CcSEcCtD
Azacitidine—Pneumonia—Doxorubicin—pancreatic cancer	1.8e-05	0.000368	CcSEcCtD
Azacitidine—Shock—Docetaxel—pancreatic cancer	1.79e-05	0.000368	CcSEcCtD
Azacitidine—Nervous system disorder—Docetaxel—pancreatic cancer	1.79e-05	0.000367	CcSEcCtD
Azacitidine—Pruritus—Fluorouracil—pancreatic cancer	1.79e-05	0.000367	CcSEcCtD
Azacitidine—Thrombocytopenia—Docetaxel—pancreatic cancer	1.79e-05	0.000366	CcSEcCtD
Azacitidine—Infestation—Doxorubicin—pancreatic cancer	1.79e-05	0.000366	CcSEcCtD
Azacitidine—Infestation NOS—Doxorubicin—pancreatic cancer	1.79e-05	0.000366	CcSEcCtD
Azacitidine—Tachycardia—Docetaxel—pancreatic cancer	1.78e-05	0.000365	CcSEcCtD
Azacitidine—Skin disorder—Docetaxel—pancreatic cancer	1.77e-05	0.000364	CcSEcCtD
Azacitidine—Diarrhoea—Gemcitabine—pancreatic cancer	1.76e-05	0.000361	CcSEcCtD
Azacitidine—Renal failure—Doxorubicin—pancreatic cancer	1.75e-05	0.00036	CcSEcCtD
Azacitidine—Dizziness—Irinotecan—pancreatic cancer	1.75e-05	0.000358	CcSEcCtD
Azacitidine—Haemoglobin—Epirubicin—pancreatic cancer	1.74e-05	0.000357	CcSEcCtD
Azacitidine—Stomatitis—Doxorubicin—pancreatic cancer	1.74e-05	0.000357	CcSEcCtD
Azacitidine—Anorexia—Docetaxel—pancreatic cancer	1.74e-05	0.000357	CcSEcCtD
Azacitidine—Rhinitis—Epirubicin—pancreatic cancer	1.74e-05	0.000356	CcSEcCtD
Azacitidine—Urinary tract infection—Doxorubicin—pancreatic cancer	1.74e-05	0.000356	CcSEcCtD
Azacitidine—Haemorrhage—Epirubicin—pancreatic cancer	1.73e-05	0.000355	CcSEcCtD
Azacitidine—Diarrhoea—Fluorouracil—pancreatic cancer	1.73e-05	0.000355	CcSEcCtD
Azacitidine—Hypoaesthesia—Epirubicin—pancreatic cancer	1.72e-05	0.000354	CcSEcCtD
Azacitidine—Pharyngitis—Epirubicin—pancreatic cancer	1.72e-05	0.000353	CcSEcCtD
Azacitidine—Urinary tract disorder—Epirubicin—pancreatic cancer	1.71e-05	0.000351	CcSEcCtD
Azacitidine—Oedema peripheral—Epirubicin—pancreatic cancer	1.71e-05	0.00035	CcSEcCtD
Azacitidine—Hypotension—Docetaxel—pancreatic cancer	1.7e-05	0.00035	CcSEcCtD
Azacitidine—Haematuria—Doxorubicin—pancreatic cancer	1.7e-05	0.000349	CcSEcCtD
Azacitidine—Connective tissue disorder—Epirubicin—pancreatic cancer	1.7e-05	0.000349	CcSEcCtD
Azacitidine—Urethral disorder—Epirubicin—pancreatic cancer	1.7e-05	0.000348	CcSEcCtD
Azacitidine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	1.69e-05	0.000346	CcSEcCtD
Azacitidine—Epistaxis—Doxorubicin—pancreatic cancer	1.68e-05	0.000345	CcSEcCtD
Azacitidine—Vomiting—Irinotecan—pancreatic cancer	1.68e-05	0.000344	CcSEcCtD
Azacitidine—Sinusitis—Doxorubicin—pancreatic cancer	1.67e-05	0.000344	CcSEcCtD
Azacitidine—Dizziness—Fluorouracil—pancreatic cancer	1.67e-05	0.000343	CcSEcCtD
Azacitidine—Agranulocytosis—Doxorubicin—pancreatic cancer	1.67e-05	0.000342	CcSEcCtD
Azacitidine—Rash—Irinotecan—pancreatic cancer	1.66e-05	0.000341	CcSEcCtD
Azacitidine—Dermatitis—Irinotecan—pancreatic cancer	1.66e-05	0.000341	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	1.66e-05	0.000341	CcSEcCtD
Azacitidine—CDA—Metabolism—APOE—pancreatic cancer	1.66e-05	0.00087	CbGpPWpGaD
Azacitidine—Headache—Irinotecan—pancreatic cancer	1.65e-05	0.000339	CcSEcCtD
Azacitidine—Insomnia—Docetaxel—pancreatic cancer	1.65e-05	0.000339	CcSEcCtD
Azacitidine—Vomiting—Gemcitabine—pancreatic cancer	1.63e-05	0.000335	CcSEcCtD
Azacitidine—Dyspnoea—Docetaxel—pancreatic cancer	1.63e-05	0.000334	CcSEcCtD
Azacitidine—Rash—Gemcitabine—pancreatic cancer	1.62e-05	0.000333	CcSEcCtD
Azacitidine—Dermatitis—Gemcitabine—pancreatic cancer	1.62e-05	0.000332	CcSEcCtD
Azacitidine—Eye disorder—Epirubicin—pancreatic cancer	1.62e-05	0.000332	CcSEcCtD
Azacitidine—Haemoglobin—Doxorubicin—pancreatic cancer	1.61e-05	0.00033	CcSEcCtD
Azacitidine—Headache—Gemcitabine—pancreatic cancer	1.61e-05	0.00033	CcSEcCtD
Azacitidine—Cardiac disorder—Epirubicin—pancreatic cancer	1.61e-05	0.00033	CcSEcCtD
Azacitidine—Vomiting—Fluorouracil—pancreatic cancer	1.61e-05	0.00033	CcSEcCtD
Azacitidine—Rhinitis—Doxorubicin—pancreatic cancer	1.61e-05	0.00033	CcSEcCtD
Azacitidine—Dyspepsia—Docetaxel—pancreatic cancer	1.61e-05	0.000329	CcSEcCtD
Azacitidine—Haemorrhage—Doxorubicin—pancreatic cancer	1.6e-05	0.000329	CcSEcCtD
Azacitidine—Hypoaesthesia—Doxorubicin—pancreatic cancer	1.59e-05	0.000327	CcSEcCtD
Azacitidine—Rash—Fluorouracil—pancreatic cancer	1.59e-05	0.000327	CcSEcCtD
Azacitidine—Dermatitis—Fluorouracil—pancreatic cancer	1.59e-05	0.000327	CcSEcCtD
Azacitidine—Pharyngitis—Doxorubicin—pancreatic cancer	1.59e-05	0.000326	CcSEcCtD
Azacitidine—Decreased appetite—Docetaxel—pancreatic cancer	1.59e-05	0.000325	CcSEcCtD
Azacitidine—Headache—Fluorouracil—pancreatic cancer	1.58e-05	0.000325	CcSEcCtD
Azacitidine—Urinary tract disorder—Doxorubicin—pancreatic cancer	1.58e-05	0.000325	CcSEcCtD
Azacitidine—Oedema peripheral—Doxorubicin—pancreatic cancer	1.58e-05	0.000324	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	1.57e-05	0.000323	CcSEcCtD
Azacitidine—Connective tissue disorder—Doxorubicin—pancreatic cancer	1.57e-05	0.000323	CcSEcCtD
Azacitidine—Fatigue—Docetaxel—pancreatic cancer	1.57e-05	0.000323	CcSEcCtD
Azacitidine—Angiopathy—Epirubicin—pancreatic cancer	1.57e-05	0.000322	CcSEcCtD
Azacitidine—Urethral disorder—Doxorubicin—pancreatic cancer	1.57e-05	0.000322	CcSEcCtD
Azacitidine—Nausea—Irinotecan—pancreatic cancer	1.57e-05	0.000322	CcSEcCtD
Azacitidine—Immune system disorder—Epirubicin—pancreatic cancer	1.56e-05	0.000321	CcSEcCtD
Azacitidine—Mediastinal disorder—Epirubicin—pancreatic cancer	1.56e-05	0.00032	CcSEcCtD
Azacitidine—Constipation—Docetaxel—pancreatic cancer	1.56e-05	0.00032	CcSEcCtD
Azacitidine—Pain—Docetaxel—pancreatic cancer	1.56e-05	0.00032	CcSEcCtD
Azacitidine—Chills—Epirubicin—pancreatic cancer	1.55e-05	0.000319	CcSEcCtD
Azacitidine—Alopecia—Epirubicin—pancreatic cancer	1.53e-05	0.000314	CcSEcCtD
Azacitidine—Nausea—Gemcitabine—pancreatic cancer	1.53e-05	0.000313	CcSEcCtD
Azacitidine—Mental disorder—Epirubicin—pancreatic cancer	1.52e-05	0.000311	CcSEcCtD
Azacitidine—Erythema—Epirubicin—pancreatic cancer	1.51e-05	0.000309	CcSEcCtD
Azacitidine—Malnutrition—Epirubicin—pancreatic cancer	1.51e-05	0.000309	CcSEcCtD
Azacitidine—Feeling abnormal—Docetaxel—pancreatic cancer	1.5e-05	0.000308	CcSEcCtD
Azacitidine—Nausea—Fluorouracil—pancreatic cancer	1.5e-05	0.000308	CcSEcCtD
Azacitidine—Eye disorder—Doxorubicin—pancreatic cancer	1.5e-05	0.000307	CcSEcCtD
Azacitidine—CDA—Metabolism—PIK3CG—pancreatic cancer	1.5e-05	0.000785	CbGpPWpGaD
Azacitidine—Gastrointestinal pain—Docetaxel—pancreatic cancer	1.49e-05	0.000306	CcSEcCtD
Azacitidine—Cardiac disorder—Doxorubicin—pancreatic cancer	1.49e-05	0.000305	CcSEcCtD
Azacitidine—Back pain—Epirubicin—pancreatic cancer	1.46e-05	0.000299	CcSEcCtD
Azacitidine—Angiopathy—Doxorubicin—pancreatic cancer	1.45e-05	0.000298	CcSEcCtD
Azacitidine—Muscle spasms—Epirubicin—pancreatic cancer	1.45e-05	0.000297	CcSEcCtD
Azacitidine—Immune system disorder—Doxorubicin—pancreatic cancer	1.45e-05	0.000297	CcSEcCtD
Azacitidine—Mediastinal disorder—Doxorubicin—pancreatic cancer	1.44e-05	0.000296	CcSEcCtD
Azacitidine—CDA—Metabolism—PPARG—pancreatic cancer	1.44e-05	0.000757	CbGpPWpGaD
Azacitidine—Abdominal pain—Docetaxel—pancreatic cancer	1.44e-05	0.000296	CcSEcCtD
Azacitidine—Body temperature increased—Docetaxel—pancreatic cancer	1.44e-05	0.000296	CcSEcCtD
Azacitidine—Chills—Doxorubicin—pancreatic cancer	1.44e-05	0.000295	CcSEcCtD
Azacitidine—Alopecia—Doxorubicin—pancreatic cancer	1.42e-05	0.000291	CcSEcCtD
Azacitidine—Mental disorder—Doxorubicin—pancreatic cancer	1.4e-05	0.000288	CcSEcCtD
Azacitidine—Ill-defined disorder—Epirubicin—pancreatic cancer	1.4e-05	0.000287	CcSEcCtD
Azacitidine—Erythema—Doxorubicin—pancreatic cancer	1.39e-05	0.000286	CcSEcCtD
Azacitidine—Malnutrition—Doxorubicin—pancreatic cancer	1.39e-05	0.000286	CcSEcCtD
Azacitidine—Anaemia—Epirubicin—pancreatic cancer	1.39e-05	0.000286	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—NOTCH1—pancreatic cancer	1.39e-05	0.000727	CbGpPWpGaD
Azacitidine—Malaise—Epirubicin—pancreatic cancer	1.36e-05	0.000279	CcSEcCtD
Azacitidine—Syncope—Epirubicin—pancreatic cancer	1.35e-05	0.000277	CcSEcCtD
Azacitidine—Leukopenia—Epirubicin—pancreatic cancer	1.35e-05	0.000277	CcSEcCtD
Azacitidine—Back pain—Doxorubicin—pancreatic cancer	1.35e-05	0.000277	CcSEcCtD
Azacitidine—Hypersensitivity—Docetaxel—pancreatic cancer	1.34e-05	0.000276	CcSEcCtD
Azacitidine—Muscle spasms—Doxorubicin—pancreatic cancer	1.34e-05	0.000275	CcSEcCtD
Azacitidine—Loss of consciousness—Epirubicin—pancreatic cancer	1.33e-05	0.000272	CcSEcCtD
Azacitidine—Cough—Epirubicin—pancreatic cancer	1.32e-05	0.00027	CcSEcCtD
Azacitidine—CDA—Metabolism—PIK3CD—pancreatic cancer	1.32e-05	0.00069	CbGpPWpGaD
Azacitidine—Asthenia—Docetaxel—pancreatic cancer	1.31e-05	0.000269	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—PPARG—pancreatic cancer	1.31e-05	0.000686	CbGpPWpGaD
Azacitidine—Convulsion—Epirubicin—pancreatic cancer	1.31e-05	0.000268	CcSEcCtD
Azacitidine—Hypertension—Epirubicin—pancreatic cancer	1.3e-05	0.000267	CcSEcCtD
Azacitidine—Ill-defined disorder—Doxorubicin—pancreatic cancer	1.29e-05	0.000266	CcSEcCtD
Azacitidine—Pruritus—Docetaxel—pancreatic cancer	1.29e-05	0.000265	CcSEcCtD
Azacitidine—Anaemia—Doxorubicin—pancreatic cancer	1.29e-05	0.000265	CcSEcCtD
Azacitidine—Myalgia—Epirubicin—pancreatic cancer	1.28e-05	0.000263	CcSEcCtD
Azacitidine—Chest pain—Epirubicin—pancreatic cancer	1.28e-05	0.000263	CcSEcCtD
Azacitidine—Arthralgia—Epirubicin—pancreatic cancer	1.28e-05	0.000263	CcSEcCtD
Azacitidine—Anxiety—Epirubicin—pancreatic cancer	1.28e-05	0.000262	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.27e-05	0.000262	CcSEcCtD
Azacitidine—Discomfort—Epirubicin—pancreatic cancer	1.27e-05	0.00026	CcSEcCtD
Azacitidine—Malaise—Doxorubicin—pancreatic cancer	1.26e-05	0.000258	CcSEcCtD
Azacitidine—Syncope—Doxorubicin—pancreatic cancer	1.25e-05	0.000257	CcSEcCtD
Azacitidine—Leukopenia—Doxorubicin—pancreatic cancer	1.25e-05	0.000256	CcSEcCtD
Azacitidine—Diarrhoea—Docetaxel—pancreatic cancer	1.25e-05	0.000256	CcSEcCtD
Azacitidine—Confusional state—Epirubicin—pancreatic cancer	1.24e-05	0.000255	CcSEcCtD
Azacitidine—Anaphylactic shock—Epirubicin—pancreatic cancer	1.23e-05	0.000252	CcSEcCtD
Azacitidine—Oedema—Epirubicin—pancreatic cancer	1.23e-05	0.000252	CcSEcCtD
Azacitidine—Loss of consciousness—Doxorubicin—pancreatic cancer	1.23e-05	0.000252	CcSEcCtD
Azacitidine—Infection—Epirubicin—pancreatic cancer	1.22e-05	0.000251	CcSEcCtD
Azacitidine—Cough—Doxorubicin—pancreatic cancer	1.22e-05	0.00025	CcSEcCtD
Azacitidine—Shock—Epirubicin—pancreatic cancer	1.21e-05	0.000248	CcSEcCtD
Azacitidine—Convulsion—Doxorubicin—pancreatic cancer	1.21e-05	0.000248	CcSEcCtD
Azacitidine—Nervous system disorder—Epirubicin—pancreatic cancer	1.21e-05	0.000248	CcSEcCtD
Azacitidine—Dizziness—Docetaxel—pancreatic cancer	1.21e-05	0.000248	CcSEcCtD
Azacitidine—Thrombocytopenia—Epirubicin—pancreatic cancer	1.2e-05	0.000247	CcSEcCtD
Azacitidine—Hypertension—Doxorubicin—pancreatic cancer	1.2e-05	0.000247	CcSEcCtD
Azacitidine—Tachycardia—Epirubicin—pancreatic cancer	1.2e-05	0.000246	CcSEcCtD
Azacitidine—Skin disorder—Epirubicin—pancreatic cancer	1.2e-05	0.000245	CcSEcCtD
Azacitidine—Hyperhidrosis—Epirubicin—pancreatic cancer	1.19e-05	0.000244	CcSEcCtD
Azacitidine—Myalgia—Doxorubicin—pancreatic cancer	1.19e-05	0.000244	CcSEcCtD
Azacitidine—Arthralgia—Doxorubicin—pancreatic cancer	1.19e-05	0.000244	CcSEcCtD
Azacitidine—Chest pain—Doxorubicin—pancreatic cancer	1.19e-05	0.000244	CcSEcCtD
Azacitidine—Anxiety—Doxorubicin—pancreatic cancer	1.18e-05	0.000243	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.18e-05	0.000242	CcSEcCtD
Azacitidine—Discomfort—Doxorubicin—pancreatic cancer	1.17e-05	0.000241	CcSEcCtD
Azacitidine—Anorexia—Epirubicin—pancreatic cancer	1.17e-05	0.000241	CcSEcCtD
Azacitidine—Vomiting—Docetaxel—pancreatic cancer	1.16e-05	0.000238	CcSEcCtD
Azacitidine—Rash—Docetaxel—pancreatic cancer	1.15e-05	0.000236	CcSEcCtD
Azacitidine—Hypotension—Epirubicin—pancreatic cancer	1.15e-05	0.000236	CcSEcCtD
Azacitidine—Dermatitis—Docetaxel—pancreatic cancer	1.15e-05	0.000236	CcSEcCtD
Azacitidine—Confusional state—Doxorubicin—pancreatic cancer	1.15e-05	0.000236	CcSEcCtD
Azacitidine—CDA—Metabolism—PIK3CB—pancreatic cancer	1.15e-05	0.000601	CbGpPWpGaD
Azacitidine—Headache—Docetaxel—pancreatic cancer	1.14e-05	0.000234	CcSEcCtD
Azacitidine—Anaphylactic shock—Doxorubicin—pancreatic cancer	1.14e-05	0.000234	CcSEcCtD
Azacitidine—Oedema—Doxorubicin—pancreatic cancer	1.14e-05	0.000234	CcSEcCtD
Azacitidine—CDA—Metabolism—PTGS2—pancreatic cancer	1.14e-05	0.000596	CbGpPWpGaD
Azacitidine—Infection—Doxorubicin—pancreatic cancer	1.13e-05	0.000232	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.12e-05	0.00023	CcSEcCtD
Azacitidine—Shock—Doxorubicin—pancreatic cancer	1.12e-05	0.00023	CcSEcCtD
Azacitidine—Nervous system disorder—Doxorubicin—pancreatic cancer	1.12e-05	0.000229	CcSEcCtD
Azacitidine—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.11e-05	0.000229	CcSEcCtD
Azacitidine—Insomnia—Epirubicin—pancreatic cancer	1.11e-05	0.000228	CcSEcCtD
Azacitidine—Tachycardia—Doxorubicin—pancreatic cancer	1.11e-05	0.000228	CcSEcCtD
Azacitidine—Skin disorder—Doxorubicin—pancreatic cancer	1.11e-05	0.000227	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—MYC—pancreatic cancer	1.1e-05	0.000579	CbGpPWpGaD
Azacitidine—Hyperhidrosis—Doxorubicin—pancreatic cancer	1.1e-05	0.000226	CcSEcCtD
Azacitidine—Dyspnoea—Epirubicin—pancreatic cancer	1.1e-05	0.000225	CcSEcCtD
Azacitidine—Anorexia—Doxorubicin—pancreatic cancer	1.09e-05	0.000223	CcSEcCtD
Azacitidine—Nausea—Docetaxel—pancreatic cancer	1.08e-05	0.000222	CcSEcCtD
Azacitidine—Dyspepsia—Epirubicin—pancreatic cancer	1.08e-05	0.000222	CcSEcCtD
Azacitidine—Decreased appetite—Epirubicin—pancreatic cancer	1.07e-05	0.000219	CcSEcCtD
Azacitidine—Hypotension—Doxorubicin—pancreatic cancer	1.06e-05	0.000218	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.06e-05	0.000218	CcSEcCtD
Azacitidine—Fatigue—Epirubicin—pancreatic cancer	1.06e-05	0.000218	CcSEcCtD
Azacitidine—Pain—Epirubicin—pancreatic cancer	1.05e-05	0.000216	CcSEcCtD
Azacitidine—Constipation—Epirubicin—pancreatic cancer	1.05e-05	0.000216	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.04e-05	0.000213	CcSEcCtD
Azacitidine—Insomnia—Doxorubicin—pancreatic cancer	1.03e-05	0.000211	CcSEcCtD
Azacitidine—Dyspnoea—Doxorubicin—pancreatic cancer	1.01e-05	0.000208	CcSEcCtD
Azacitidine—Feeling abnormal—Epirubicin—pancreatic cancer	1.01e-05	0.000208	CcSEcCtD
Azacitidine—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.01e-05	0.000206	CcSEcCtD
Azacitidine—Dyspepsia—Doxorubicin—pancreatic cancer	1e-05	0.000206	CcSEcCtD
Azacitidine—CDA—Metabolism—PTEN—pancreatic cancer	9.91e-06	0.00052	CbGpPWpGaD
Azacitidine—Decreased appetite—Doxorubicin—pancreatic cancer	9.9e-06	0.000203	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.83e-06	0.000202	CcSEcCtD
Azacitidine—Fatigue—Doxorubicin—pancreatic cancer	9.82e-06	0.000201	CcSEcCtD
Azacitidine—Urticaria—Epirubicin—pancreatic cancer	9.77e-06	0.000201	CcSEcCtD
Azacitidine—Constipation—Doxorubicin—pancreatic cancer	9.74e-06	0.0002	CcSEcCtD
Azacitidine—Pain—Doxorubicin—pancreatic cancer	9.74e-06	0.0002	CcSEcCtD
Azacitidine—Body temperature increased—Epirubicin—pancreatic cancer	9.73e-06	0.0002	CcSEcCtD
Azacitidine—Abdominal pain—Epirubicin—pancreatic cancer	9.73e-06	0.0002	CcSEcCtD
Azacitidine—Feeling abnormal—Doxorubicin—pancreatic cancer	9.38e-06	0.000193	CcSEcCtD
Azacitidine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.31e-06	0.000191	CcSEcCtD
Azacitidine—Hypersensitivity—Epirubicin—pancreatic cancer	9.07e-06	0.000186	CcSEcCtD
Azacitidine—Urticaria—Doxorubicin—pancreatic cancer	9.04e-06	0.000186	CcSEcCtD
Azacitidine—Abdominal pain—Doxorubicin—pancreatic cancer	9e-06	0.000185	CcSEcCtD
Azacitidine—Body temperature increased—Doxorubicin—pancreatic cancer	9e-06	0.000185	CcSEcCtD
Azacitidine—Asthenia—Epirubicin—pancreatic cancer	8.83e-06	0.000181	CcSEcCtD
Azacitidine—Pruritus—Epirubicin—pancreatic cancer	8.71e-06	0.000179	CcSEcCtD
Azacitidine—Diarrhoea—Epirubicin—pancreatic cancer	8.42e-06	0.000173	CcSEcCtD
Azacitidine—Hypersensitivity—Doxorubicin—pancreatic cancer	8.39e-06	0.000172	CcSEcCtD
Azacitidine—Asthenia—Doxorubicin—pancreatic cancer	8.17e-06	0.000168	CcSEcCtD
Azacitidine—Dizziness—Epirubicin—pancreatic cancer	8.14e-06	0.000167	CcSEcCtD
Azacitidine—Pruritus—Doxorubicin—pancreatic cancer	8.05e-06	0.000165	CcSEcCtD
Azacitidine—Vomiting—Epirubicin—pancreatic cancer	7.82e-06	0.000161	CcSEcCtD
Azacitidine—Diarrhoea—Doxorubicin—pancreatic cancer	7.79e-06	0.00016	CcSEcCtD
Azacitidine—Rash—Epirubicin—pancreatic cancer	7.76e-06	0.000159	CcSEcCtD
Azacitidine—Dermatitis—Epirubicin—pancreatic cancer	7.75e-06	0.000159	CcSEcCtD
Azacitidine—Headache—Epirubicin—pancreatic cancer	7.71e-06	0.000158	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—AKT1—pancreatic cancer	7.66e-06	0.000402	CbGpPWpGaD
Azacitidine—Dizziness—Doxorubicin—pancreatic cancer	7.53e-06	0.000154	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—MYC—pancreatic cancer	7.46e-06	0.000391	CbGpPWpGaD
Azacitidine—Nausea—Epirubicin—pancreatic cancer	7.31e-06	0.00015	CcSEcCtD
Azacitidine—Vomiting—Doxorubicin—pancreatic cancer	7.24e-06	0.000149	CcSEcCtD
Azacitidine—Rash—Doxorubicin—pancreatic cancer	7.18e-06	0.000147	CcSEcCtD
Azacitidine—Dermatitis—Doxorubicin—pancreatic cancer	7.17e-06	0.000147	CcSEcCtD
Azacitidine—Headache—Doxorubicin—pancreatic cancer	7.13e-06	0.000146	CcSEcCtD
Azacitidine—CDA—Metabolism—PIK3CA—pancreatic cancer	6.99e-06	0.000367	CbGpPWpGaD
Azacitidine—Nausea—Doxorubicin—pancreatic cancer	6.76e-06	0.000139	CcSEcCtD
Azacitidine—CDA—Metabolism—AKT1—pancreatic cancer	5.71e-06	0.000299	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—AKT1—pancreatic cancer	5.17e-06	0.000271	CbGpPWpGaD
